Advanced search
Publication Cover
Psoriasis: Targets and Therapy Volume 11, 2021 - Issue
Submit an article Journal homepage
516
Views
7
CrossRef citations to date
0
Altmetric
Review

Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies

Deepak M W Balak1 Department of Dermatology, LangeLand Ziekenhuis, Zoetermeer, the Netherlands;2 Department of Dermatology, Ghent University Hospital, Ghent, BelgiumCorrespondence[email protected]
View further author information
,
Stefano Piaserico3 Dermatology Unit, Department of Medicine, University of Padova, Padova, ItalyView further author information
&
Ismail Kasujee4 Almirall GMA, Barcelona, SpainView further author information
Pages 151-168 | Published online: 07 Dec 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Eveline De Brandt & Tom Hillary. (2022) Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal Management. Psoriasis: Targets and Therapy 12, pages 113-126.
Read now

Articles from other publishers (6)

Kelly Torosian, Esha Lal, Arthur Kavanaugh, Rohit Loomba, Veeral Ajmera & Monica Guma. (2023) Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review. Seminars in Arthritis and Rheumatism 59, pages 152165.
Crossref
Antonio Olveira, Salvador Augustin, Salvador Benlloch, Javier Ampuero, Jorge Alonso Suárez-Pérez, Susana Armesto, Eva Vilarrasa, Isabel Belinchón-Romero, Pedro Herranz, Javier Crespo, Francisco Guimerá, Lara Gómez-Labrador, Víctor Martín & José Manuel Carrascosa. (2023) The Essential Role of IL-17 as the Pathogenetic Link between Psoriasis and Metabolic-Associated Fatty Liver Disease. Life 13:2, pages 419.
Crossref
Abdul Q. Khan, Maha Victor Agha, Khalid Sultan A.M. Sheikhan, Shahd M. Younis, Maha Al Tamimi, Majid Alam, Aamir Ahmad, Shahab Uddin, Joerg Buddenkotte & Martin Steinhoff. (2022) Targeting deregulated oxidative stress in skin inflammatory diseases: An update on clinical importance. Biomedicine & Pharmacotherapy 154, pages 113601.
Crossref
Stefano Piaserico, Gloria Orlando & Francesco Messina. (2022) Psoriasis and Cardiometabolic Diseases: Shared Genetic and Molecular Pathways. International Journal of Molecular Sciences 23:16, pages 9063.
Crossref
Baochen Li, Rui Su, Huanhuan Yan, Juanjuan Liu, Chong Gao, Xiaofeng Li & Caihong Wang. (2022) Immunological risk factors for nonalcoholic fatty liver disease in patients with psoriatic arthritis: New predictive nomograms and natural killer cells. Frontiers in Immunology 13.
Crossref
Giovanni Damiani, Giulia Odorici, Alessia Pacifico, Aldo Morrone, Rosalynn R. Z. Conic, Tima Davidson, Abdulla Watad, Paolo D. M. Pigatto, Delia Colombo, Piergiorgio Malagoli & Marco Fiore. (2022) Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching. Pharmaceuticals 15:1, pages 95.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.